Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Albumin BCP

K-Number: K193001 · 2019-12-19

Decision Date2019-12-19
Product CodeCJW
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Albumin BCP is the device name listed in this FDA 510(k) record. The listed applicant is SENTINEL CH. SpA. It received FDA 510(k) clearance on 2019-12-19 under 510(k) number K193001. The device is classified under product code CJW. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Albumin BCP?

Albumin BCP is a medical device that received FDA 510(k) clearance on 2019-12-19. The listed applicant is SENTINEL CH. SpA. The 510(k) number is K193001.

When did Albumin BCP receive FDA 510(k) clearance?

Albumin BCP received FDA 510(k) clearance on 2019-12-19, under 510(k) number K193001.

Who is the listed applicant for Albumin BCP?

The FDA 510(k) record lists SENTINEL CH. SpA as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Albumin BCP?

The FDA product code for Albumin BCP is CJW.

Other records listing SENTINEL CH. SpA as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: CJW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.